Abbott/OraSure
This article was originally published in The Gray Sheet
Executive Summary
Abbott will exclusively distribute OraSure's OraQuick Advance HIV-1/2 rapid antibody test to U.S. hospitals under a Feb. 14 deal. OraQuick is the only rapid, point-of-care test approved for oral fluid, finger stick whole blood and plasma. Both firms will market to physician offices. OraSure will retain exclusive access to government agencies, community groups...